VicPlas International Faces Revenue Decline Amid Plant Expansion

VicPlas International Ltd. (SG:569) has released an update.

Don't Miss our Black Friday Offers:

VicPlas International Ltd reported a 20.8% decline in revenue for FY2024, largely due to a 30.3% drop in its medical devices segment, resulting in a loss of $1.36 million. The decline was attributed to reduced post-pandemic inventory levels and increased operating costs from plant expansions in Changzhou and Mexico. The company’s new Mexico plant is nearing completion and is expected to contribute to revenue by the second half of FY2025.

For further insights into SG:569 stock, check out TipRanks’ Stock Analysis page.

Trending Articles

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

More Related Articles

Info icon

This data feed is not available at this time.

Data is currently not available

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.